Ross Galin > O'Melveny & Myers LLP > New York, United States > Lawyer Profile
O'Melveny & Myers LLP Offices

TIMES SQUARE TOWER
7 TIMES SQUARE
NEW YORK, NY 10036
NEW YORK
United States
- Firm Profile
- Go to...
Ross Galin

Work Department
White Collar Defense & Corporate Investigations; Life Sciences
Position
Partner
Education
- Fordham University, J.D.: cum laude; Order of the Coif; Managing Editor, Fordham Law Review
- University of Michigan, B.A., Political Science, B.A., History; Class Honors for Academic Achievement
Lawyer Rankings
United States > Industry focus > Healthcare: life sciences
O’Melveny & Myers LLP is known for its broad portfolio of work, advising pharmaceutical companies on core transactions and representing them in litigations, alongside supplementing M&A with a focus on venture capital clients, with a presence in multiple pharmaceutical development markets. The contentious arm advises on product liability, antitrust and trade secrets cases. Most notably, the team is lead counsel for Johnson & Johnson in its Opioid-related cases. New York-based Lisa Pensabene and Ross Galin are key litigators focusing on IP. Scott Elliott leads transactions from San Francisco and Steve Brody leads the compliance and product liability teams from Washington DC. New York-based patent and medical tech litigator Hassen Sayeed is also recommended.
Lawyer Rankings
Top Tier Firm Rankings
- Labor and employment > ERISA litigation
- Industry focus > Insurance: advice to insurers
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Intellectual property > Trade secrets (litigation and non-contentious matters)
Firm Rankings
- Industry focus > Energy: renewable/alternative power
- Industry focus > Environment: transactional
- Industry focus > Healthcare: health insurers
- Labor and employment > Labor and employment disputes (including collective actions): defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Finance > Restructuring (including bankruptcy): municipal
- Dispute resolution > Securities litigation: defense
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Intellectual property > Copyright
- Dispute resolution > General commercial disputes
- Labor and employment > Labor-management relations
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Industry focus > Sport
- Industry focus > Transport: aviation and air travel - litigation and regulation
- Tax > US taxes: non-contentious
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Industry focus > Healthcare: life sciences
- International Trade > International trade
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Finance > Restructuring (including bankruptcy): corporate
- Intellectual property > Trademarks: litigation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Industry focus > Energy regulation: electric power
- Finance > Project finance